Literature DB >> 20812330

Short pediatric Crohn's disease activity index for quality improvement and observational research.

Michael D Kappelman1, Wallace V Crandall, Richard B Colletti, Anthony Goudie, Ian H Leibowitz, Lynn Duffy, David E Milov, Sandra C Kim, Bess T Schoen, Ashish S Patel, John Grunow, Evette Larry, Gerry Fairbrother, Peter Margolis.   

Abstract

BACKGROUND: Practical and objective instruments to assess pediatric Crohn's disease (CD) activity are required for observational research and quality improvement. The objectives were: 1) to determine the feasibility of completing the Pediatric Crohn's Disease Activity Index (PCDAI) and the Abbreviated PCDAI (APCDAI); and 2) to create a Short PCDAI by retaining and reweighting the most practical and informative components.
METHODS: Physicians in the ImproveCareNow Collaborative for pediatric inflammatory bowel disease (IBD) were asked to record components of the PCDAI and assign a Physician Global Assessment (PGA) of disease severity at each patient encounter. We assessed the feasibility of the PCDAI, the APCDAI, and the individual index components by determining the proportion of visits in which data were recorded. We created a short index by retaining and reweighting components of the PCDAI completed in ≥80% of visits. The feasibility of the Short PCDAI and its ability to discriminate between PGA categories were evaluated using descriptive statistics.
RESULTS: This study population included 1355 subjects with CD (6373 visits). The PCDAI and APCDAI were complete in 16.7% and 44.1% of visits, respectively. A Short PCDAI, including general well-being, abdominal pain, stools, weight, abdominal exam, and extraintestinal manifestations were completed in 66.5% of visits. The correlation between the Short PCDAI and PGA was similar to that of the PCDAI (r = 0.60, P < 0.001 versus 0.61, P < 0.001).
CONCLUSIONS: The Short PCDAI is a practical and valid tool to measure pediatric CD activity. Its use should facilitate quality improvement and observational research.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20812330      PMCID: PMC2998542          DOI: 10.1002/ibd.21452

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  17 in total

Review 1.  The quality of life in patients with Crohn's disease.

Authors:  R D Cohen
Journal:  Aliment Pharmacol Ther       Date:  2002-09       Impact factor: 8.171

2.  Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original?

Authors:  Melissa A Shepanski; Jonathan E Markowitz; Petar Mamula; Linda B Hurd; Robert N Baldassano
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-07       Impact factor: 2.839

3.  Development of a Crohn's index for survey research.

Authors:  R S Sandler; M C Jordan; L L Kupper
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

4.  Development and validation of a pediatric Crohn's disease activity index.

Authors:  J S Hyams; G D Ferry; F S Mandel; J D Gryboski; P M Kibort; B S Kirschner; A M Griffiths; A J Katz; R J Grand; J T Boyle
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-05       Impact factor: 2.839

5.  Morbidity of juvenile onset inflammatory bowel disease: effects on education and employment in early adult life.

Authors:  A Ferguson; D M Sedgwick; J Drummond
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 6.  The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review.

Authors:  E V Loftus; P Schoenfeld; W J Sandborn
Journal:  Aliment Pharmacol Ther       Date:  2002-01       Impact factor: 8.171

7.  Assessing activity of pediatric Crohn's disease: which index to use?

Authors:  A Otley; H Loonen; N Parekh; M Corey; P M Sherman; A M Griffiths
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

8.  Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study.

Authors:  Eva Szigethy; Anna Levy-Warren; Sarah Whitton; Athos Bousvaros; Kimberlee Gauvreau; Alan M Leichtner; William R Beardslee
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-10       Impact factor: 2.839

9.  Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey.

Authors:  Teresa Longobardi; Philip Jacobs; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

10.  A critical assessment of items on the Pediatric Crohn's Disease Activity Index.

Authors:  H J Loonen; A M Griffiths; M P Merkus; H H F Derkx
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-01       Impact factor: 2.839

View more
  36 in total

1.  Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.

Authors:  Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Eva M Szigethy; Ruud Beukers; Thea A Korpershoek; Sabine D M Theuns-Valks; Manon H J Hillegers; Johanna C Escher; Elisabeth M W J Utens
Journal:  J Pediatr Psychol       Date:  2018-10-01

2.  Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs.

Authors:  Kevin A Hommel; Meghan E McGrady; James Peugh; George Zacur; Katherine Loreaux; Shehzad Saeed; Elizabeth Williams; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2017-09       Impact factor: 5.325

3.  Changes in health-related quality of life over a 1-year follow-up period in children with inflammatory bowel disease.

Authors:  Helene Werner; Markus A Landolt; Patrick Buehr; Rebekka Koller; Andreas Nydegger; Johannes Spalinger; Klaas Heyland; Susanne Schibli; Christian P Braegger
Journal:  Qual Life Res       Date:  2017-02-14       Impact factor: 4.147

4.  Detecting inflammation in inflammatory bowel disease - how does ultrasound compare to magnetic resonance enterography using standardised scoring systems?

Authors:  Joy L Barber; Alexsandra Zambrano-Perez; Øystein E Olsen; Fevronia Kiparissi; Mila Baycheva; Daniela Knaflez; Neil Shah; Tom A Watson
Journal:  Pediatr Radiol       Date:  2018-04-13

5.  Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.

Authors:  Millie D Long; Wallace V Crandall; Ian H Leibowitz; Lynn Duffy; Fernando del Rosario; Sandra C Kim; Mark J Integlia; James Berman; John Grunow; Richard B Colletti; Bess T Schoen; Ashish S Patel; Howard Baron; Esther Israel; George Russell; Sabina Ali; Hans H Herfarth; Christopher Martin; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2010-12-17       Impact factor: 5.325

6.  Accuracy of the medication list in the electronic health record-implications for care, research, and improvement.

Authors:  Kathleen E Walsh; Keith A Marsolo; Cori Davis; Theresa Todd; Bernadette Martineau; Carlie Arbaugh; Frederique Verly; Charles Samson; Peter Margolis
Journal:  J Am Med Inform Assoc       Date:  2018-07-01       Impact factor: 4.497

7.  Health-related quality of life in youth with Crohn disease: role of disease activity and parenting stress.

Authors:  Wendy N Gray; Shana L Boyle; Danielle M Graef; David M Janicke; Christopher D Jolley; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-06       Impact factor: 2.839

8.  Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.

Authors:  Phillip Minar; Yael Haberman; Ingrid Jurickova; Ting Wen; Marc E Rothenberg; Mi-Ok Kim; Shehzad A Saeed; Robert N Baldassano; Michael Stephens; James Markowitz; Joel Rosh; Wallace V Crandall; Melvin B Heyman; David R Mack; Anne M Griffiths; Susan S Baker; Jeffrey S Hyams; Subra Kugathasan; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

9.  Effectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health system.

Authors:  Christopher B Forrest; Wallace V Crandall; L Charles Bailey; Peixin Zhang; Marshall M Joffe; Richard B Colletti; Jeremy Adler; Howard I Baron; James Berman; Fernando del Rosario; Andrew B Grossman; Edward J Hoffenberg; Esther J Israel; Sandra C Kim; Jenifer R Lightdale; Peter A Margolis; Keith Marsolo; Devendra I Mehta; David E Milov; Ashish S Patel; Jeanne Tung; Michael D Kappelman
Journal:  Pediatrics       Date:  2014-06-16       Impact factor: 7.124

10.  Rates and predictors of oral medication adherence in pediatric patients with IBD.

Authors:  Neal S LeLeiko; Debra Lobato; Sarah Hagin; Elizabeth McQuaid; Ronald Seifer; Sheryl J Kopel; Julie Boergers; Jack Nassau; Kristina Suorsa; Jason Shapiro; Barbara Bancroft
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.